Cargando…

VISTA: A Target to Manage the Innate Cytokine Storm

In recent years, the success of immunotherapy targeting immunoregulatory receptors (immune checkpoints) in cancer have generated enthusiastic support to target these receptors in a wide range of other immune related diseases. While the overwhelming focus has been on blockade of these inhibitory path...

Descripción completa

Detalles Bibliográficos
Autores principales:	ElTanbouly, Mohamed A., Zhao, Yanding, Schaafsma, Evelien, Burns, Christopher M., Mabaera, Rodwell, Cheng, Chao, Noelle, Randolph J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905033/ https://www.ncbi.nlm.nih.gov/pubmed/33643285 http://dx.doi.org/10.3389/fimmu.2020.595950

Ejemplares similares

VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways
por: ElTanbouly, Mohamed A., et al.
Publicado: (2020)

Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness
por: Broughton, Thomas W. K., et al.
Publicado: (2019)

Influence of T Cell-Mediated Immune Surveillance on Somatic Mutation Occurrences in Melanoma
por: Jiang, Chongming, et al.
Publicado: (2022)

VISTA expression and patient selection for immune-based anticancer therapy
por: Martin, Alexander S., et al.
Publicado: (2023)

Blocking the VISTA pathway enhances disease progression in (NZB × NZW) F1 female mice
por: Sergent, PA, et al.
Publicado: (2017)

Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy
por: Zhao, Yanding, et al.
Publicado: (2020)

COVID-19: In the Eye of the Cytokine Storm
por: de la Rica, Roberto, et al.
Publicado: (2020)

Controlling Cytokine Storm Is Vital in COVID-19
por: Tang, Lu, et al.
Publicado: (2020)

Quantification of Cytokine Storms During Virus Infections
por: Yuan, Shu, et al.
Publicado: (2021)

Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

The COVID-19 Cytokine Storm; What We Know So Far
por: Ragab, Dina, et al.
Publicado: (2020)

Computational STAT3 activity inference reveals its roles in the pancreatic tumor microenvironment
por: Schaafsma, Evelien, et al.
Publicado: (2019)

Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells
por: Wang, Lu, et al.
Publicado: (2021)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
por: Tang, Yujun, et al.
Publicado: (2020)

Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in”
por: Castelli, Vanessa, et al.
Publicado: (2020)

Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids
por: Miao, Yi, et al.
Publicado: (2020)

Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm
por: Liu, Zhijun, et al.
Publicado: (2021)

Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients
por: Shcherbak, Sergey G., et al.
Publicado: (2021)

Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration
por: Chen, Ruirong, et al.
Publicado: (2021)

Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity
por: Marcuzzi, Annalisa, et al.
Publicado: (2021)

Ponatinib Protects Mice From Lethal Influenza Infection by Suppressing Cytokine Storm
por: Chen, Si, et al.
Publicado: (2019)

Four cases of cytokine storm after COVID-19 vaccination: Case report
por: Murata, Kazuhiro, et al.
Publicado: (2022)

Structural Basis of VSIG3: The Ligand for VISTA
por: Xie, Xiaoxue, et al.
Publicado: (2021)

A New VISTA on combination therapy for negative checkpoint regulator blockade
por: Deng, Jie, et al.
Publicado: (2016)

Apoptotic Cells for Therapeutic Use in Cytokine Storm Associated With Sepsis– A Phase Ib Clinical Trial
por: van Heerden, Peter Vernon, et al.
Publicado: (2021)

Exploring the VISTA of microglia: immune checkpoints in CNS inflammation
por: Borggrewe, Malte, et al.
Publicado: (2020)

Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
por: Karki, Rajendra, et al.
Publicado: (2022)

Fine Tuning the Cytokine Storm by IFN and IL-10 Following Neurotropic Coronavirus Encephalomyelitis
por: Savarin, Carine, et al.
Publicado: (2018)

Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm
por: Gonzalez-Rubio, Jesus, et al.
Publicado: (2020)

Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal
por: Shabrish, Snehal, et al.
Publicado: (2021)

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
por: Meng, Jianfen, et al.
Publicado: (2021)

Peramivir, an Anti-Influenza Virus Drug, Exhibits Potential Anti-Cytokine Storm Effects
por: Zhang, Chen-xi, et al.
Publicado: (2022)

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics
por: Chavda, Vivek P., et al.
Publicado: (2023)

Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone
por: Afzal, Muhammad Zubair, et al.
Publicado: (2018)

Editorial: Secretion of Cytokines and Chemokines by Innate Immune Cells
por: Lacy, Paige
Publicado: (2015)

COVID-19 cytokine storm: targeting the appropriate cytokine
por: Cron, Randy Q
Publicado: (2021)

Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm?
por: Vignesh, Ramachandran, et al.
Publicado: (2021)

High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs
por: Aswad, Miran, et al.
Publicado: (2022)

Cytokine Storm
por: Fajgenbaum, David C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9a3vm5qh69svuurkak72s8nkom